`

Seraxis

Biotechnology Research

Specialities :
Cell therapy
Regenerative medicine
Stem cells
Type 1 diabetes
Organ replacement

+2

revenue-icon Revenue
1M - 10M
funding-icon Total Funding
--
size-icon Size
11 - 50

Frequently Asked Questions About Seraxis

What does Seraxis do?+

Seraxis is bringing transformative therapies to the millions of people worldwide struggling with the management of insulin-requiring diabetes and the associated life-threatening complications. Seraxis lead program, SR-02, is a novel islet replacement therapy for patients of insulin-requiring diabetes with concurrent immunosuppression therapy. This therapy is the foundation of Seraxis follow-on therapies for patients without immune suppression. Frazier Life Sciences, Polaris Partners, Eli Lilly and Company, the T1D Fund and others are investors in Seraxis

What are Seraxis's specialties? +

Cell therapy,regenerative medicine,stem cells,type 1 diabetes,organ replacement,functional endocrine pancreas,and off-the-shelf implants

What is Seraxis's industry? +

Seraxis operates in the Biotechnology research industry.

What is Seraxis's revenue? +

Seraxis's revenue is 1m - 10m

What is Seraxis's company size? +

Seraxis has 11 - 50 employees.

The Go-to Sales Technology According to G2

G2 Badges Map
Get Started With Clodura
Sign Up

Sign Up for Free

Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.

Supercharge Your Prospecting

Supercharge Your Prospecting

Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.

Grow Your Business

Grow Your Business

Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.